Vertex Announces Webcasts of its Presentations at Two Investor Conferences

Wednesday, February 27, 2013

Vertex Announces Webcasts of its Presentations at Two Investor Conferences16:45 EST Wednesday, February 27, 2013
CAMBRIDGE, Mass. (Business Wire) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
Vertex will webcast its presentation at the 33rd Annual Cowen Health
Care Conference on Tuesday, March 5, 2013 at 8:40 a.m. ET and at the
Barclays Global Healthcare Conference on Tuesday, March 12, 2013 at 1:00
p.m. ET.
The presentations will be webcast live and may be accessed from the
‘Events & Presentations' link under the ‘Investors' tab on the home page
of Vertex's website at www.vrtx.com.
A replay of the webcasts will also be available on the Company's website
for two weeks following the presentations. To ensure a timely
connection, it is recommended that users register at least 15 minutes
prior to the scheduled webcast.
About Vertex
Vertex creates new possibilities in medicine. Our team discovers,
develops and commercializes innovative therapies so people with serious
diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to
cure or significantly advance the treatment of hepatitis C, cystic
fibrosis, rheumatoid arthritis and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, Mass., we now have ongoing
worldwide research programs and sites in the U.S., U.K. and Canada.
Today, Vertex has more than 2,000 employees around the world, and for
three years in a row, Science magazine has named Vertex one of
its Top Employers in the life sciences.
Vertex's press releases are available at www.vrtx.com.
(VRTX-WEB)
Vertex Pharmaceuticals IncorporatedKelly Lewis, 617-961-7530Director,
Investor Relations

Restrictions

All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. ‘Thomson Reuters’ and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.